SCHEMBL6294396

SCHEMBL6294396

NNC(=O)NCC1CCC(C(=O)OC(=O)C(F)(F)F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 1/20 0.34
EPHX1 P07099 3/20 0.34
EPHX2 P34913 1/20 0.34
HDAC6 Q9UBN7 3/20 0.33
MLYCD O95822 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
GFER P55789 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
MMP12 P39900 1/20 0.31
CYP2C19 P33261 1/20 0.31
KDM4E B2RXH2 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL939950 0.83 TDP1 (0.37) TDP1ALDH1A1CYP3A4EPHX1EPHX2
Trifluoroacetic Acid SCHEMBL7418767 0.79 PLG (0.43) TDP1ALDH1A1CYP3A4EPHX1EPHX2
Trifluoroacetic Acid SCHEMBL939948 0.79 PLG (0.43) TDP1ALDH1A1CYP3A4EPHX1EPHX2
SCHEMBL31270861 0.78
SCHEMBL6256278 0.76 HTT (0.31) TDP1KMT2ASMN1; SMN2
SCHEMBL21813738 0.75 TDP1 (0.44) TDP1ALDH1A1CYP3A4EPHX1EPHX2
SCHEMBL940065 0.75 PLG (0.52) TDP1ALDH1A1CYP3A4EPHX1NPC1
SCHEMBL7430073 0.75 PLG (0.52) TDP1ALDH1A1CYP3A4EPHX1NPC1
SCHEMBL27514511 0.74 MEN1 (0.30) KMT2AMEN1
SCHEMBL775473 0.70 CES2 (0.37) TDP1ALDH1A1HDAC6KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101506185-B Oxolane is [3,2-B] pyrroles-3-ketone intermediate also 格兰泰有限公司 2016-06-29 CN disclosed
US-6958358-B2 administering a cystatin; 4-tert-Butyl-N-[2-(4-hydroxyphenyl)-1S-(3-oxo-hexahydrocyclopenta[b]furan-3a-ylcarbamoyl)-ethyl]benzamide; bioassay for validation of efficacy ; Chagas' disease; parasiticide, trypanocide AMURA THERAPEUTICS LIMITED (GB) 2005-10-25 US disclosed
US-6245743-B1 ADMINISTERING ARGININE-CONTAINING OLIGOPEPTIDE AS ANTICOAGULANT; CARDIOVASCULAR DISORDERS COR THERAPEUTICS, INC. 2001-06-12 US disclosed
US-6046169-A Inhibitors of factor XA COR THERAPEUTICS, INC. (US) 2000-04-04 US disclosed
US-5919765-A USING A (DI- OR TRI)PEPTIDES COR THERAPEUTICS, INC. (US) 1999-07-06 US disclosed
EP-0846125-A2 INHIBITORS OF FACTOR Xa COR THERAPEUTICS, INC. (US) 1998-06-10 EP disclosed
US-5721214-A PEPTIDE ANTICOAGULANTS COR THERAPEUTICS, INC. (US) 1998-02-24 US disclosed